EUVIMEDEUVIMED entdecken
Crossref

Orally Administrated Precision Nanomedicine for Restoring the Intestinal Barrier and Alleviating Inflammation in Treatment of Inflammatory Bowel Disease

Ding Wang, Qi Jiang, Peirong Li, Caini Yu, Renxiang Yuan, Zhefan Dong, Tingting Meng, Fuqiang Hu iD, Jianwei Wang, Hong Yuan iD

ACS Applied Materials & Interfaces · 19.02.2025 · 17 (7) · 10986-11001

DOI: 10.1021/acsami.4c19742 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 11.02.2025. Verfasst von Ding Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Science, Zhejiang University, Hangzhou 310058, P. R. China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Anti-Inflammatory Agents, Nanomedicine, Quercetin. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesAnti-Inflammatory AgentsNanomedicineQuercetinIntestinal MucosaAnimalsAdministration, OralHumansMiceInflammationDrug CarriersDexamethasoneProdrugsDrug LiberationGastrointestinal Microbiome

Stichwörter der Autor:innen

controlled releaseinflammatory bowel diseaseoral deliveryreactive oxygen species-responsivetargeted therapy

Substanzen

Anti-Inflammatory AgentsQuercetinDrug CarriersDexamethasoneProdrugs

Autor:innen und Institutionen

  • College of Pharmaceutical Science, Zhejiang University, Hangzhou 310058, P. R. China.
  • Jinhua Institute of Zhejiang University, Jinhua 321299, P. R. China.
  • The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, P. R. China.

ORCID-Profile: Fuqiang Hu, Hong Yuan

Förderung

  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Wang, D., Jiang, Q., Li, P., Yu, C., Yuan, R., Dong, Z., Meng, T., Hu, F., Wang, J., & Yuan, H. (2025). Orally Administrated Precision Nanomedicine for Restoring the Intestinal Barrier and Alleviating Inflammation in Treatment of Inflammatory Bowel Disease. ACS Applied Materials & Interfaces, 17(7), 10986-11001. https://doi.org/10.1021/acsami.4c19742

Vancouver

Wang D, Jiang Q, Li P, Yu C, Yuan R, Dong Z, et al. Orally Administrated Precision Nanomedicine for Restoring the Intestinal Barrier and Alleviating Inflammation in Treatment of Inflammatory Bowel Disease. ACS Applied Materials & Interfaces. 2025;17(7):10986-11001. doi:10.1021/acsami.4c19742

BibTeX
@article{Wang2025,
  author = {Wang, Ding and Jiang, Qi and Li, Peirong and Yu, Caini and Yuan, Renxiang and Dong, Zhefan and Meng, Tingting and Hu, Fuqiang and Wang, Jianwei and Yuan, Hong},
  title = {Orally Administrated Precision Nanomedicine for Restoring the Intestinal Barrier and Alleviating Inflammation in Treatment of Inflammatory Bowel Disease},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  volume = {17},
  number = {7},
  pages = {10986--11001},
  doi = {10.1021/acsami.4c19742}
}
Kostenlos starten →